Lifescience Innovator
KODE™ technology is a platform technology with the ability to modify surfaces (cells, virions, liposomes, non-biological membranes) with bioactive compounds including carbohydrates, peptides, proteins, and many other structures. The process is simple, robust and cells and virions maintain vitality and functionality.
KODE Biotech Limited
KODE Biotech is the licensor of the KODE™ technology platform. We are strongly committed to maximizing the use and publication of KODE™ technology, and are interested in working with new commercial or research partners to achieve this. We will construct user-defined FSLs for our collaborators and licensees. KODE™ Technology has already been licensed in specific fields to major international commercial and academic organizations. There are presently several commercial products in the market, and KODE™ constructs for research use can be obtained from Sigma-Aldrich or KODE Biotech Materials Ltd.
